BNP Paribas Financial Markets
IMVT icon

BNP Paribas Financial Markets’s Immunovant IMVT Stock Holding History

BNP Paribas Financial Markets’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Sell
320,071
-14,486
-4% -$441K ﹤0.01% 1514
2026
Q1 		$8.31M Sell
334,557
-18,499
-5% -$479K ﹤0.01% 1676
2025
Q4 		$8.97M Sell
353,056
-330,346
-48% -$7.37M ﹤0.01% 1682
2025
Q3 		$11M Buy
683,402
+385,232
+129% +$6.24M 0.01% 1476
2025
Q2 		$4.77M Buy
298,170
+176,121
+144% +$2.66M ﹤0.01% 1895
2025
Q1 		$2.09M Buy
122,049
+36,848
+43% +$771K ﹤0.01% 2342
2024
Q4 		$2.11M Buy
+85,201
New +$2.42M ﹤0.01% 2331

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BNP Paribas Financial Markets's IMVT Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Immunovant (IMVT) stake by 4.3% in Q2 2026, selling an estimated $441K and leaving 320,071 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

BNP Paribas Financial Markets first reported a position in IMVT in Q4 2024 and has held it in 7 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • BNP Paribas Financial Markets held 320,071 shares of Immunovant worth $12.3M as of Q2 2026.
  • BNP Paribas Financial Markets sold 14,486 Immunovant shares in Q2 2026, an estimated $441K.
  • Immunovant made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1514 holding.
  • BNP Paribas Financial Markets first reported a position in Immunovant in Q4 2024 and has held it in 7 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.